Today's gain is good, but will be dwarfed by Monday's gain if the HTI-501 data is favorable tomorrow
The update tomorrow on the Phase II HTI-501 study at the 9th World Congress of Cosmetic Dermatology in Greece is a much bigger deal than the news today (although a positive). A treatment to smooth out the dimple in the skin (cellulite) of women is a HUGE market. Moreover, since HALO is developing it by itself they can reap higher profits, even if they need to partner with big Pharmadown the road to bring it to market.
At some point, HALO becomes a takeover candidate, if not now. Good luck to all longs!
I agree with your comments, however, please keep in mind that cellulite can be a problem for women who are not overweight, too. Certainly, the more one weighs the larger the potential problem. In any case, women will pay big dollars to improve how they look in a bathing suit and other clothes.